Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Receivables: 2021-2024

Historic Change in Receivables for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Dec 2024 value amounting to $3.6 million.

  • Rhythm Pharmaceuticals' Change in Receivables rose 286.42% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year increase of 171.79%. This contributed to the annual value of $3.6 million for FY2024, which is 57.83% down from last year.
  • Rhythm Pharmaceuticals' Change in Receivables amounted to $3.6 million in FY2024, which was down 57.83% from $8.6 million recorded in FY2023.
  • In the past 5 years, Rhythm Pharmaceuticals' Change in Receivables registered a high of $8.6 million during FY2023, and its lowest value of $1.2 million during FY2021.
  • For the 3-year period, Rhythm Pharmaceuticals' Change in Receivables averaged around $5.8 million, with its median value being $5.2 million (2022).
  • In the last 5 years, Rhythm Pharmaceuticals' Change in Receivables surged by 315.92% in 2022 and then plummeted by 57.83% in 2024.
  • Yearly analysis of 4 years shows Rhythm Pharmaceuticals' Change in Receivables stood at $1.2 million in 2021, then surged by 315.92% to $5.2 million in 2022, then skyrocketed by 66.24% to $8.6 million in 2023, then tumbled by 57.83% to $3.6 million in 2024.